Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 10:33 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 149 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Urinary Incontinence, Urge Clear all

Conditions: Lower Urinary Tract Symptoms, Stress Urinary Incontinence, Urge Urinary Incontinence, Overactive Bladder, Pelvic Organ Prolapse, Weight Loss, Fecal Incontinence, Bariatric Surgery, glp1 Agonist
Interventions: Bariatric Surgery, GLP1 receptor agonist; Procedure · Drug
Lead sponsor: Hartford HealthCare; Other
Eligibility: 18 Years to 90 Years · Female only
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Overactive Bladder With Urge Urinary Incontinence
Interventions: URO-902, Placebo; Drug
Lead sponsor: Urovant Sciences GmbH; Industry
Eligibility: 40 Years to 79 Years · Female only
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 20
States / cities: Mobile, Alabama • Tucson, Arizona • Laguna Hills, California + 17 more

Conditions: Urinary Incontinence
Interventions: VA Video Connect, MyHealtheBladder; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older · Female only
Enrollment: 286 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 3
States / cities: Birmingham, Alabama • Decatur, Georgia • Durham, North Carolina

Conditions: Urinary Incontinence, Urge
Interventions: Anticholinergic medications, Hypnotherapy; Drug · Behavioral
Lead sponsor: University of New Mexico; Other
Eligibility: 18 Years and older · Female only
Enrollment: 165 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Urinary Incontinence
Interventions: Bladder diary, Questionnaires, Urodynamics, Pad weight; Other · Procedure
Lead sponsor: University of Rochester; Other
Eligibility: 21 Years and older · Female only
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Overactive Bladder, Urinary Urge Incontinence, Overactive Bladder Syndrome, Urinary Incontinence, Urge, Urge Incontinence, Urinary Urgency, Urinary Frequency
Interventions: OnabotulinumtoxinA 100 UNT [Botox]; Drug
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years and older · Female only
Enrollment: 116 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Orange, California

Conditions: Overactive Bladder
Interventions: Urgent PC Neuromodulation System, Tolterodine; Device · Drug
Lead sponsor: Uroplasty, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Minnetonka, Minnesota

Conditions: Overactive Bladder (OAB), Urge Incontinence
Interventions: onabotulinum toxin type a; Drug
Lead sponsor: Alexis Dieter; Other
Eligibility: 55 Years and older · Female only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Urinary Incontinence
Interventions: Multi-modal rehabilitation program, Pelvic Floor Physical therapy; Other
Lead sponsor: Howard University; Other
Eligibility: 65 Years and older · Female only
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Urinary Incontinence
Interventions: Instructional DVD, Bladder Health Class; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 55 Years and older · Female only
Enrollment: 647 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2015
U.S. locations: 2
States / cities: Ann Arbor, Michigan • Philadelphia, Pennsylvania

Conditions: Urinary Urge Incontinence (UUI), Urinary Frequency (UF), Fecal Incontinence (FI), Overactive Bladder (OAB)
Interventions: Axonics External Trial System (ETS); Device
Lead sponsor: Axonics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 3
States / cities: Birmingham, Alabama • Macon, Georgia • West Columbia, South Carolina

Conditions: Urge Incontinence, Urinary Incontinence, Urge
Interventions: Mirabegron, Tolterodine Tartrate; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 65 Years and older · Female only
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Overactive Bladder
Interventions: AOBO-001, Placebo; Drug
Lead sponsor: American Oriental Bioengineering, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 5
States / cities: Mobile, Alabama • West Palm Beach, Florida • Newton, Kansas + 2 more

Conditions: Urinary Incontinence, Stress, Urinary Incontinence, Urge
Interventions: Miduretheral Sling, Miduretheral Sling with behavioral/pelvic floor therapy; Procedure · Other
Lead sponsor: NICHD Pelvic Floor Disorders Network; Network
Eligibility: 21 Years and older · Female only
Enrollment: 480 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 10
States / cities: Birmingham, Alabama • Downey, California • La Jolla, California + 7 more

Conditions: Urinary Incontinence, Urge
Interventions: oxybutynin; Drug
Lead sponsor: FemmePharma Global Healthcare, Inc.; Industry
Eligibility: 18 Years to 75 Years · Female only
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 2
States / cities: Baltimore, Maryland • Hackensack, New Jersey

Conditions: Urge Urinary Incontinence
Interventions: Biofeedback, pelvic floor muscle training, fMRI; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 60 Years and older · Female only
Enrollment: 123 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2016
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Urinary Incontinence
Interventions: Tolterodine ER 4 mg QD, Tamsulosin 0.4 mg QD; Drug
Lead sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.; Industry
Eligibility: 40 Years and older · Male only
Enrollment: 830 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 95
States / cities: Birmingham, Alabama • Homewood, Alabama • Tucson, Arizona + 92 more

Conditions: Urinary Incontinence
Interventions: Office evaluation, UDS; Other
Lead sponsor: Carelon Research; Other
Eligibility: 21 Years and older · Female only
Enrollment: 630 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 10
States / cities: Birmingham, Alabama • San Diego, California • Maywood, Illinois + 7 more

Conditions: Overactive Bladder, Urinary Frequency, Urinary Incontinence, Urge, Urinary Urgency
Interventions: Wearable Bladder Modulation System; Device
Lead sponsor: Avation Medical, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 9
States / cities: Stanford, California • Denver, Colorado • Englewood, Colorado + 6 more

Conditions: Urinary Urge Incontinence
Interventions: Neuspera Implantable Sacral Neuromodulation System; Device
Lead sponsor: Neuspera Medical, Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Urinary Incontinence
Interventions: Athena Pelvic Muscle Trainer; Device
Lead sponsor: Athena Feminine Technologies, Inc.; Industry
Eligibility: 30 Years to 70 Years · Female only
Enrollment: 462 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 96
States / cities: Birmingham, Alabama • Dothan, Alabama • Casa Grande, Arizona + 87 more

Conditions: Urinary Urge, Urge Incontinence, Overactive Bladder
Interventions: solifenacin succinate, placebo; Drug
Lead sponsor: Stamford Hospital; Other
Eligibility: 20 Years to 45 Years · Female only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 2
States / cities: Stamford, Connecticut

Conditions: Urinary Bladder, Overactive, Urinary Incontinence, Urge
Interventions: eLearning; Other
Lead sponsor: Kathleen O'Connell; Other
Eligibility: 40 Years to 64 Years · Female only
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Overactive Bladder, Urge Incontinence, Incontinence, Urinary, Urinary Urge Incontinence
Interventions: eCoin Tibial Nerve Stimulation; Device
Lead sponsor: Valencia Technologies Corporation; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 4
States / cities: Newport Beach, California • Waterloo, Iowa • Greensboro, North Carolina + 1 more

Search by objective public record fields.

Pelvic Floor Disorder Symptoms in Women Seeking Weight Loss Therapy

URO-902 in Female Subjects With Overactive Bladder and Urge Urinary Incontinence

Remote Access to Urinary Incontinence Treatment for Women Veterans

Brain-Centered Therapy Versus Medication for Urgency Urinary Incontinence : Hypnotherapy Or Pharmacotherapy

Randomized Trial for Botox Urinary Incontinence

Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial

Overactive Bladder Innovative Therapy Trial (OrBIT)

Assessing the Genitourinary Microbiome of Women With Overactive Bladder Undergoing Onabotulinum Toxin Type A Intradetrusor Injections

Functional Assessment and Muscle Evaluation Through Exercise Trial

Translating Unique Learning for Incontinence Prevention

Aquarius Pilot Study to Evaluate the New Axonics Trial System

Treatment of Incontinence Without Memory Problems

Study of AOBO-001 for Overactive Bladder With Urge Urinary Incontinence and Frequency

Combined Treatment for Mixed Incontinence

A Study of Oxybutynin for the Treatment of Urge Urinary Incontinence

Further Enhancing Non-pharmacologic Therapy for Incontinence

Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet Obstruction

Value of Urodynamic Evaluation

FREEOAB Study for Overactive Bladder

Neuspera Revision Registry - Follow up Revision Experience and Evaluation of Device Outcomes Metrics

Athena Pelvic Muscle Trainer - DUETS Trial

Solifenacin Succinate Versus Placebo in Inner City Women Ages 20-45 With Overactive Bladder

Efficacy of Animated Videos to Foster Healthy Bladder Behaviors in Community Women

eCoin for OAB Feasibility Follow-on Study